pamidronate has been researched along with Spinal Neoplasms in 6 studies
Spinal Neoplasms: New abnormal growth of tissue in the SPINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate disodium is a second-generation biphosphonate, a group of compounds that are being used increasingly to inhibit bone resorption in disorders that are characterized by excessive bone loss such, as hypercalcemia of malignancy, osteoporosis, and Paget's disease." | 5.29 | Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site. ( Ford, JM; Fuji, T; Fushimi, H; Tanaka, M, 1996) |
| "Autopsy specimens of a bone metastasis from a woman with a primary squamous cell carcinoma of the tongue who developed multiple osteolytic lesions and hypercalcemia and was treated with pamidronate were studied histologically, histochemically, and ultrastructurally." | 3.69 | Effects of bisphosphonate (pamidronate) on bone resorption resulting from metastasis of a squamous cell carcinoma: report of an autopsy case and evaluation of bone resorbing activity in an experimental animal model. ( Hiraga, T; Nakajima, T; Ozawa, H; Takada, M, 1996) |
| "The various features of carcinoid tumors metastasizing to the skeleton are briefly reviewed." | 1.31 | Case of an ivory vertebra. ( Ball, DW; Basaria, S; Belzberg, AJ; McCarthy, EF, 2000) |
| "Pamidronate disodium is a second-generation biphosphonate, a group of compounds that are being used increasingly to inhibit bone resorption in disorders that are characterized by excessive bone loss such, as hypercalcemia of malignancy, osteoporosis, and Paget's disease." | 1.29 | Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site. ( Ford, JM; Fuji, T; Fushimi, H; Tanaka, M, 1996) |
| " In the present study we have evaluated the therapeutic efficacy of pamidronate (3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid) combined with mitomycin C (MMC) on bone metastasis of breast cancer using an animal model." | 1.29 | Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model. ( Enomoto, K; Ikeda, T; Ishii, S; Kitajima, M; Tamura, H; Wada, N, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, M | 1 |
| Fushimi, H | 1 |
| Fuji, T | 1 |
| Ford, JM | 1 |
| Tamura, H | 1 |
| Ishii, S | 1 |
| Ikeda, T | 1 |
| Wada, N | 1 |
| Enomoto, K | 1 |
| Kitajima, M | 1 |
| Hiraga, T | 1 |
| Takada, M | 1 |
| Nakajima, T | 1 |
| Ozawa, H | 1 |
| Basaria, S | 1 |
| McCarthy, EF | 1 |
| Belzberg, AJ | 1 |
| Ball, DW | 1 |
| Korfel, A | 1 |
| Fischer, L | 1 |
| Foss, HD | 1 |
| Koch, HC | 1 |
| Thiel, E | 1 |
| Masud, T | 1 |
| Slevin, ML | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for pamidronate and Spinal Neoplasms
| Article | Year |
|---|---|
Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site.
Topics: Adenocarcinoma; Cervical Vertebrae; Diphosphonates; Female; Humans; Middle Aged; Neoplasms, Unknown | 1996 |
Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Neoplasms; Diphosphonates; | 1996 |
Effects of bisphosphonate (pamidronate) on bone resorption resulting from metastasis of a squamous cell carcinoma: report of an autopsy case and evaluation of bone resorbing activity in an experimental animal model.
Topics: Acid Phosphatase; Aged; Animals; Bone Neoplasms; Bone Resorption; Carcinoma, Squamous Cell; Diphosph | 1996 |
Case of an ivory vertebra.
Topics: Alendronate; Alkaline Phosphatase; Biopsy; Bone Marrow; Carcinoid Tumor; Diagnosis, Differential; Di | 2000 |
Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cell Differentiation; Cisp | 2001 |
Pamidronate to reduce bone pain in normocalcaemic patient with disseminated prostatic carcinoma.
Topics: Adenocarcinoma; Calcium; Diphosphonates; Humans; Male; Middle Aged; Pain Measurement; Pain, Intracta | 1989 |